Lesport Emilie, Commeau Lucie, Genet Mélanie, Baulieu Etienne-Emile, Tawk Marcel, Giustiniani Julien
Institut Professeur Baulieu, INSERM U1195, Kremlin-Bicêtre, France.
INSERM U1195, Université Paris-Saclay, Kremlin-Bicêtre, France.
Front Cell Neurosci. 2024 Jul 25;18:1425222. doi: 10.3389/fncel.2024.1425222. eCollection 2024.
The failure of the autophagy-lysosomal pathway to clear the pathogenic forms of Tau exacerbates the pathogenesis of tauopathies. We have previously shown that the immunophilin FKBP52 interacts both physically and functionally with Tau, and that a decrease in FKBP52 protein levels is associated with Tau deposition in affected human brains. We have also shown that FKBP52 is physiologically present within the lysosomal system in healthy human neurons and that a decrease in FKBP52 expression alters perinuclear lysosomal positioning and Tau clearance during Tau-induced proteotoxic stress . In this study, we generate a zebrafish loss of function mutant and show that axonal retrograde trafficking of Lamp1 vesicles is altered in this mutant. Moreover, using our transgenic line, we demonstrate that the autophagic flux is impaired in mutant embryos, suggesting a role for Fkbp52 in the maturation of autophagic vesicles. Alterations in both axonal transport and autophagic flux are more evident in heterozygous rather than homozygous mutants. Finally, taking advantage of the previously described A152T-Tau transgenic fish, we show that the clearance of pathogenic A152T-Tau mutant proteins is slower in mutants in comparison to larvae. Altogether, these results indicate that Fkbp52 is required for the normal trafficking and maturation of lysosomes and autophagic vacuoles along axons, and that its decrease is sufficient to hinder the clearance of pathogenic Tau .
自噬 - 溶酶体途径清除病理性Tau蛋白的功能失败会加剧tau蛋白病的发病机制。我们之前已经表明,免疫亲和蛋白FKBP52在物理和功能上均与Tau相互作用,并且FKBP52蛋白水平的降低与受影响人类大脑中的Tau沉积有关。我们还表明,FKBP52在健康人类神经元的溶酶体系统中正常存在,并且在Tau诱导的蛋白毒性应激期间,FKBP52表达的降低会改变核周溶酶体的定位和Tau的清除。在本研究中,我们构建了一个斑马鱼功能缺失突变体,并表明该突变体中Lamp1囊泡的轴突逆行运输发生了改变。此外,利用我们的转基因品系,我们证明突变体胚胎中的自噬通量受损,这表明Fkbp52在自噬囊泡的成熟中发挥作用。轴突运输和自噬通量的改变在杂合突变体中比纯合突变体中更明显。最后,利用先前描述的A152T - Tau转基因鱼,我们表明与野生型幼虫相比,突变体中致病性A152T - Tau突变蛋白的清除更慢。总之,这些结果表明Fkbp52是溶酶体和自噬泡沿轴突正常运输和成熟所必需的,其减少足以阻碍致病性Tau的清除。